On the recordJuly 25, 2019
CREATES addresses a tactic the company that makes Revlimid, Celgene, uses to deny generic companies access to samples of Revlimid.
Source
congress.govCREATES addresses a tactic the company that makes Revlimid, Celgene, uses to deny generic companies access to samples of Revlimid.
Discussing the CREATES Act to improve access to generic medications.
Share
More from Jim Jordan
He’s done a good job as a member of Congress and we should all pray for his family.
Members of Congress’ communications are protected under the Speech or Debate Clause. Jack Smith knows this. But he ignored the Constitution to spy on Republicans.
This action confirms that the platform's fraud prevention measures were not as robust as [ActBlue CEO Regina Wallace-Jones] told Congress. We will continue to demand answers.